AGIO Latest Quarter’s Earnings
Announce Date11/5/2026
EPS Actual (USD)-1.09
Revenue Actual (USD)--
Agios Pharmaceuticals Inc Earnings Dates & Reports
This page offers detailed Agios Pharmaceuticals Inc earnings data including the latest Agios Pharmaceuticals Inc earnings report, the upcoming Agios Pharmaceuticals Inc earnings date, historical data and Agios Pharmaceuticals Inc earnings call news.
AGIO Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
AGIO FY2025 Earnings
EPS (YoY)-7.12-160.04%
Revenue (YoY)54.03M48.03%
Agios Pharmaceuticals Inc (AGIO) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 11/5/2026 | 09/2026 | -1.09/-1.21 | --/-- | 10.29% | -- |
| 7/30/2026 | 06/2026 | -1.69/-1.67 | 44.74M/25.52M | -1.49% | 75.32% |
| 4/29/2026 | 03/2026 | -1.69/-1.80 | 20.75M/13.65M | 6.37% | 52.03% |
| 2/12/2026 | 12/2025 | -1.85/-1.95 | 19.97M/12.01M | 4.87% | 66.20% |
| 10/30/2025 | 09/2025 | -1.78/-1.90 | 12.88M/10.42M | 6.30% | 23.64% |
| 7/31/2025 | 06/2025 | -1.93/-1.81 | 12.46M/9.48M | -6.98% | 31.39% |
| 5/1/2025 | 03/2025 | -1.55/-1.78 | 8.73M/9.64M | 12.88% | -9.48% |
| 2/13/2025 | 12/2024 | -1.69/-1.69 | 10.73M/9.33M | -0.02% | 15.04% |
Agios Pharmaceuticals Inc Latest Earnings Call Transcripts
Agios (AGIO) Q3 2026 Earnings Call: Revenue Reaches $55.4M
Agios Q3 2026 revenue reached $55.4 million as AQVESME expanded, while the FDA moved mitapivat’s sickle cell PDUFA date to February 1, 2027.